Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

1.0K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.0K
Structure and Function of Platelets01:18

Structure and Function of Platelets

2.8K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
2.8K
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

8.6K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
8.6K
Therapeutic Drug Monitoring: Overview and Classification01:16

Therapeutic Drug Monitoring: Overview and Classification

270
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
270
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

182
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
182
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

1.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of a hemolysis filter system for the selective removal of free hemoglobin, haem and iron from blood envisaged for use in extracorporeal circuits.

Scientific reports·2026
Same author

Does your patient education material for low back pain meet patients' information and education needs? Preliminary development of a new checklist.

Musculoskeletal science & practice·2026
Same author

Assessing patient education materials about low back pain for understandability, actionability, quality, readability, accuracy, comprehensiveness, and coverage of information about patients' needs.

Musculoskeletal science & practice·2025
Same author

Laboratory and Molecular Diagnosis of Factor XI Deficiency.

Seminars in thrombosis and hemostasis·2024
Same author

Interpretation of coagulation laboratory tests for patients on ECMO.

International journal of laboratory hematology·2024
Same author

Implementation of a day-stay joint replacement pathway in an Australian regional public hospital: A descriptive study.

The Australian journal of rural health·2024
Same journal

Endothelial Cell Phenotypic Plasticity in Atherosclerosis.

Handbook of experimental pharmacology·2026
Same journal

Endothelial Dysfunction and Neurovascular Alterations in Autism Spectrum Disorder.

Handbook of experimental pharmacology·2026
Same journal

Molecular Mechanisms of Endothelial Shear Stress Mechanotransduction in Health and Disease.

Handbook of experimental pharmacology·2026
Same journal

Microvasculature of the Pancreatic Islets of Langerhans in Health and Diabetes.

Handbook of experimental pharmacology·2026
Same journal

Mechanisms of Actions of Physiological, Pharmacological, and Toxicological Dietary Bioactive Inorganic Boron.

Handbook of experimental pharmacology·2026
Same journal

BNCT Plus Luminescence: New Paradigm for Boron-Containing Drug Design.

Handbook of experimental pharmacology·2026
See all related articles

Related Experiment Video

Updated: Jan 8, 2026

Dynamic Multiparameter Platelet Function Assessment Using a Capacitive Biosensor
06:32

Dynamic Multiparameter Platelet Function Assessment Using a Capacitive Biosensor

Published on: May 2, 2025

733

Platelet Function Tests and Monitoring Antiplatelet Therapies.

Simon Davidson1

  • 1Faculty of Medical Science, Division of Medicine, University College London, London, UK. simon.davidson@ucl.ac.uk.

Handbook of Experimental Pharmacology
|December 15, 2025
PubMed
Summary
This summary is machine-generated.

Platelet function testing helps personalize antiplatelet therapy, like with clopidogrel (a P2Y12 inhibitor), and manage bleeding risks before cardiac surgery. This review examines point-of-care tests and recent evidence.

Keywords:
Antiplatelet monitoringAspirinMultiplateP2Y12 inhibitorsPFARotemTEGVerifyNow

More Related Videos

Microfluidics in Assessing Platelet Function
06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

1.5K
A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
09:38

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

14.3K

Related Experiment Videos

Last Updated: Jan 8, 2026

Dynamic Multiparameter Platelet Function Assessment Using a Capacitive Biosensor
06:32

Dynamic Multiparameter Platelet Function Assessment Using a Capacitive Biosensor

Published on: May 2, 2025

733
Microfluidics in Assessing Platelet Function
06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

1.5K
A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
09:38

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

14.3K

Area of Science:

  • Cardiology
  • Hematology
  • Clinical Pharmacology

Background:

  • The introduction of clopidogrel (a P2Y12 inhibitor) in the late 1990s highlighted significant inter-individual variability in patient response.
  • Emerging platelet function tests (PFTs) coincided with clopidogrel's adoption, prompting research into their clinical utility.
  • PFTs were considered for tailoring antiplatelet therapy and managing perioperative risks in cardiac surgery patients.

Purpose of the Study:

  • To explore the role and effectiveness of widely used platelet function tests.
  • To focus on point-of-care (POC) or minimally processed laboratory tests.
  • To review recent guidelines and clinical trial evidence on PFTs in specific clinical scenarios.

Main Methods:

  • Review of widely used platelet function tests, emphasizing POC methods.
  • Analysis of recent clinical guidelines and evidence from clinical trials.
  • Building upon previously published foundational work on platelet function testing.

Main Results:

  • Significant variability in patient response to clopidogrel necessitates personalized treatment approaches.
  • Platelet function testing is valuable for guiding antiplatelet therapy and assessing perioperative bleeding and thrombotic risks.
  • Point-of-care testing offers practical solutions for timely clinical decision-making.

Conclusions:

  • Platelet function testing plays a crucial role in optimizing antiplatelet therapy and perioperative management.
  • The evidence supports the utility of PFTs, particularly POC assays, in clinical practice.
  • Continued research and guideline updates are essential for refining the application of PFTs.